Early-Stage

• Funding Early-Stage Bioscience Companies: Do You Have What It Takes?
• Putting Together the Right Team: Management, Board of Directors, and Scientific Advisory Boards
• Valuation of an Early-Stage Bioscience Company

Mid-Stage

• Mid-Stage Company Strategic Alliances: Trends, Deal Terms, Timing, and Structuring Considerations
• Invention vs. Acquisition: Strategies for Successful Pipeline Growth
• What, When, Why, and How: Acquiring Capabilities to Support Your Commercialization Strategy

Late-Stage

• Outsourcing: Best Practices and Lessons Learned from an Industry Perspective
• Preparing for Launch: An Overview of Essential Legal and Regulatory Requirements for Marketing and Selling Prescription Drugs in the U.S.
• Exit Strategies: Managing Risk and Reward

Business

• Molecular Diagnostics and Disease Management
• Commercialization Strategies
• The Media:  Trends, Challenges, and Opportunities - How Bioscience Executives Work Effectively with News and Trade Press

Drug Delivery, Device, and Diagnostics

• Drug-Device Combinations: Challenges and Lessons Learned
• Therapeutic Delivery: Regulatory Challenges and 505(b)(2)
• Patent Wars: New Landscape, New Strategies

Finance

• The Current Landscape for Alternative and Traditional Financing
• Challenges and Opportunities of the IPO Market and Related Strategies
• Global Capital Markets: Benefits and Risks

Hot Topics in Science

• The Need for and the Prospects of New and Improved Vaccines
• The Science of Follow-on Proteins and Biological Products
• Advancing Obesity Therapeutics